Boston Scientific Corporation Price Today
Boston Scientific Corporation
BSX
Healthcare
$72.92B
๐ฐ
Market Cap
86.0
๐ธ
Price to Earnings
$0.6
๐
EPS
+74
๐ณ
ESG
Consensus Recommendations
Buy Consensus
Buy |
19 |
Strong Buy |
13 |
Hold |
5 |
Sell |
0 |
Strong Sell |
0 |
BSX Price Forecast Target
50.7 ๐ 68.0 +34%
BSX EPS Forecast
0.6 ๐ 2.2 +280%
Financials
Profit Margin
7 %
Revenue Growth
10.9 %
Dividend
$ 0
Held Percent
0.3% - Insiders
94.2% - Institutions
5.5% - Public
Major Fund Holders
-
๐ฐ Blackrock Inc. $7.0B
-
๐ฐ Vanguard Group Inc $6.1B
-
๐ฐ FMR, LLC $5.8B
-
๐ฐ Massachusetts Financial Services Co. $4.0B
-
๐ฐ State Street Corporation $3.1B
Stock Ideas
Bill Gates Portfolio
With a portfolio valued at over $18 billion, the Bill & Melinda Gates Foundation Trust holds the endowment and funds the Bill & Melinda Gates Foundation. Bill and Melinda are the trustees for the Foundation Trust, and the endowment is managed by a tโฆDavid Einhorn Portfolio
David Einhorn is one of the most successful long/short equity hedge fund managers of the past decade. As of July 2013, David Einhornโs Greenlight Capital has returned 19.5% since its inception in 1996. Greenlight Capitalโs market beta is around 0.5,โฆRon Baron Portfolio
Ron Baron is an American billionaire investor, entrepreneur, and the founder of Baron Capital Group, a well-known investment management firm. He is recognized for his long-term, growth-oriented investment approach and has built a successful track reโฆStanley Druckenmiller Portfolio
Stanley Druckenmiller is a legendary hedge fund manager who has made billions of dollars for his investors. His current portfolio is heavily invested in gold, silver, and other precious metals. He also owns shares in several technology and healthcarโฆ๐ฎFAQ
Some Frequently Asked Questions.
The Boston Scientific Corporation industry is Medical Devices
The Boston Scientific Corporation sector is Healthcare
The Boston Scientific Corporation forecasted predicted Price to Earnings PE ratio is 22.6
The Boston Scientific Corporation Price to Earnings PE ratio is 86.0
The Market Capitalization of Boston Scientific Corporation is $72.92B
There are total of 1460079511 float shares with 94.2% held by Institutions and 0.3% held by insiders
The MBoston Scientific Corporation forecasted Earnings per Share EPS is $2.2
The Boston Scientific Corporation Earnings per Share EPS is 0.6
The Boston Scientific Corporation company has $8679000000 gross profits with 7 profit margins
The Boston Scientific Corporation Earnings Growth is 0.059% with 0.038% quarterly earnings growth
The Boston Scientific Corporation Revenue is $13400000512 with 0.109 revenue growth
The price target for Boston Scientific Corporation stock is $68.0 for the high target and $55.0 for the low target
The consensus analyst recommendations for Boston Scientific Corporation is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Boston Scientific Corporation is Buy, with the following breakdown:
- Buy: 19
- Strong Buy: 13
- Hold: 5
- Sell: 0
- Strong Sell: 0
The Beta of Boston Scientific Corporation is 0.8
The dividend of Boston Scientific Corporation is $0
The dividend yield of Boston Scientific Corporation is 0%
The biggest institutional and mutual fund holders of Boston Scientific Corporation stock are
- Blackrock Inc.
- Vanguard Group Inc
- FMR, LLC
- Massachusetts Financial Services Co.
The Boston Scientific Corporation ESG Score is 74, with the following breakdown:
- E: 3.0
- S: 12.69
- G: 10.63